Clinical Trial Update: Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY） [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial investigating targeted antibody-drug conjugates for HER2 ultra-low or no expression in advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING